NCT04728269View on ClinicalTrials.gov

Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

December 9, 2020

Study Completion Date

December 9, 2020

Conditions

Atopic Dermatitis

Interventions

OTHER

Lactibiane Topic AD

Application of Lactibiane topic AD twice a day (morning and evening) on one lesional area

OTHER

Placebo

Application of placebo twice a day (morning and evening) on the symmetrical lesional area

Trial Locations (1)

69495

Unité de Recherche Clinique en Immunologie - Lyon Sud, Pierre-Bénite

All Listed Sponsors

lead

PiLeJe

INDUSTRY

NCT04728269 - Exploratory Study on Lactibiane Topic AD on Skin Flora and Barrier Reinforcement in Mild to Moderate Atopic Dermatitis | Biotech Hunter | Biotech Hunter